Key Market Insights

• Currently, over 100 firms claim to offer a variety of novel digital manufacturing solutions in order to cater to the rising demand for biopharmaceuticals
• 140+ platforms, based on PAT, DAS, MES, digital twins and other such technologies, are being offered for digitalization of the biologic production process
• Over 85% of the process analytical technologies are capable of offering process automation and bioprocess optimization and controls; majority of these platforms support manufacturing of proteins and antibodies
• Data analysis software offer a wide spectrum of technical competencies, including process intelligence and data integration; predominantly, these platforms are compatible with artificial intelligence-based programs
• Leveraging their expertise, ~80% players are offering cloud-based MES solutions that can be integrated with numerous types of software to carry out production tracking, performance analysis and data integration functions
• The developer landscape is dominated by the presence of established players; asset / process management emerged as the prominent application areas for digital twin technologies
• In pursuit of gaining a competitive edge, digital biomanufacturing providers are upgrading their existing software capabilities and enhancing their biologic focused technology portfolios
• The growing preference for digitalization of bioprocessing is evident from the rise in partnership activity; it is worth highlighting that more than 80% of the deals were forged in the last three years
• Being a relatively concentrated market, players are focused on developing unique selling propositions for their technology platforms and become strategic partners for biologic developers
• The adoption of digital biomanufacturing solutions has increased considerably in recent years; white spaces in this domain present significant growth opportunities for innovators
• Fundamental advancements in the field of smart biomanufacturing will promote process robustness and product quality; this will inevitably culminate in accelerated growth of the market
• Driven by the continuous technological innovations, this domain is anticipated to witness steady growth; technologies focused on digital twins are expected to gain significant traction with an annualized growth of 26%
• The projected opportunity for digital bioprocessing platforms is expected to be well distributed across different types of biologics and key geographical regions

Table of Contents

1. PREFACE

1.1.      Introduction

1.2.       Key Market Insights 

1.3.      Scope of the Report

1.4.       Research Methodology

1.5.      Frequently Asked Questions

1.6.       Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1.      Chapter Overview

3.2.      Overview of Digital manufacturing in Healthcare

3.3.      Emerging Technologies that Support Digital Biomanufacturing

3.4.      Challenges Associated with the Adoption of Digital Biomanufacturing

3.5.      Future Perspectives

4. MARKERT LANDSCAPE

4.1.      Chapter Overview

4.2.      List of Process Analytical Technology (PAT) Providers

4.3.      List of Data Analysis Software (DAS) Providers

4.4.        List of Manufacturing Execution Systems (MES) Providers

4.5.      List of Digital Twins Providers

5. TECHNOLOGY COMPETITIVENESS ANALYSIS

5.1.      Chapter Overview

5.2.      Assumptions and Key Parameters

5.3.      Methodology

5.4.      Technology Competitiveness Analysis: Process Analytical Technologies

5.5.      Technology Competitiveness Analysis: Data Analysis Software

5.6.      Technology Competitiveness Analysis: Manufacturing Execution Systems

5.7.      Technology Competitiveness Analysis: Digital Twins

6. COMPANY PROFILES

6.1.      Chapter Overview

6.2.      AspenTech

6.3.      FUJIFILM Diosynth Biotechnologies

6.4.      Merck

6.5.      Thermo Fisher Scientific

6.6.      Bioreactors.net

6.7.      Sartorius

6.8.      Dassault Systèmes

6.9.      GE Healthcare

6.10.    Körber

7. BENCHMARKING ANALYSIS

7.1.      Chapter Overview

7.2.      Methodology and Key Assumptions

7.3.      Competitive Benchmarking by Company Size and Region

7.4.      Competitive Benchmarking: Pockets of Innovation and White Spaces

8. PARTNERSHIPS AND COLLABORATIONS

8.1.      Chapter Overview

8.2.      Partnership Models

8.3.      Digital Biomanufacturing: List of Partnerships and Collaborations

9. MARKET CONCENTRATION ANALYSIS

9.1.      Chapter Overview

9.2.      Assumptions and Key Parameters

9.3.      Methodology

9.4.      Market Concertation Analysis: Top Digital Biomanufacturing Providers

10. INDUSTRY LIFECYCLE ANALYSIS

10.1.    Chapter Overview

10.2.    Industry Lifecycle Analysis

10.3.    Digital Biomanufacturing: Historical Timeline of Key Events

10.4.    Digital Biomanufacturing: Start-up Activity

10.5.    Digital Biomanufacturing: Established Players Activity

10.6.    Digital Biomanufacturing: Partnership and Collaboration Trends

10.7.    Digital Biomanufacturing: Funding and Investments Trends

10.8.    Current Barriers to Wider Adoption of Digitalization in Biomanufacturing

10.9.    Future Outlook of Digital Biomanufacturing

10.10. Industry Lifecycle Analysis: Digital Biomanufacturing

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS

11.1.    Chapter Overview

11.2.    Forecast Methodology and Key Assumptions

11.3.    Global Digital Biomanufacturing Market, 2023-2035

11.4.    Digital manufacturing Market: Analysis by Type of Technology

11.5.    Digital Biomanufacturing Market: Analysis by Type of Deployment Options

11.6.    Digital Biomanufacturing Market: Analysis by Type(s) of Biologic(s) Manufactured

11.7.    Digital Biomanufacturing Market: Analysis by Geography

12. CONCLUDING REMARKS

13. APPENDIX I: TABULATED DATA

14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html

News article

Global Digital Therapeutics Market

Learn from experts:  do you know about these emerging industry trends?

Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders

4D Bioprinting Market: Key Trends

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com